Related Experiment Videos
[A case of Pringle-Bourneville disease associated with neurofibromatosis]
Actas Dermo-Sifiliograficas
|July 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Quality-of-Life Analysis of a Phase II Randomised Controlled Trial Comparing Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy in Locally Advanced Rectal Cancer.
Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Patterns of acute inferior wall myocardial infarction caused by hyperkalemia.
Journal of electrocardiology·2001
[Breast, cervical and colo-rectal simultaneous mass screening program for women 50 to 69 years old in Isere].
Sante publique (Vandoeuvre-les-Nancy, France)·2000
Reverse alternating Wenckebach periods and other modes of regression of > or = 8:1 to 2:1 atrioventricular block.
The American journal of cardiology·1998
Onychomycosis: clinical and dermoscopic characteristics, diagnosis, and therapeutic management.
Actas dermo-sifiliograficas·2026
AEDV 2025-2030 Strategic Plan for Public-Sector Dermatology.
Actas dermo-sifiliograficas·2026
Thioredoxin system: mechanisms and therapeutic potential in mental disorders.
Frontiers in pharmacology·2026
Short-term Classification of Neurodegenerative Diseases using Time-series Features Based on Analysis of Gait Dynamics.
Journal of biomedical physics & engineering·2026
Nuclear protein in testis midline carcinoma of nasal cavity: a case report and review of the literature.
Frontiers in oncology·2026
Apathy-depression overlap: unmasking hidden disability profiles in multiple sclerosis.
Frontiers in neurology·2026
Veratramine Alleviates Neuropathic Pain in Male Rats With Chronic Constriction Injury and Inhibits the PI3K/Akt Pathway.
European journal of pain (London, England)·2026
Inhibition of Cerebellar Dentate Nucleus-Zona Incerta Glutamatergic Circuit Improves Sleep Disturbances in Chronic Temporal Lobe Epilepsy Model.
CNS neuroscience & therapeutics·2026